Dolutegravir / lamivudine (Dovato®) for treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection in adults and adolescents above 12 years of age weighing at least 40 kg, with no known or suspected resistance to the integrase inhibitor class, or lamivudine (February 2020) Recommended
lack or loss of strength
sleep problems (insomnia)
, Tenorio A
If you experience any of these symptoms, stop taking dolutegravir and lamivudine and call your doctor immediately or get emergency
(A) Comparison of symptoms during ART in two groups; (B) Change of laboratory indicators at week 48 in
The aim of this study was to analyze the effectiveness
Dolutegravir is available in a fixed-dose combination with tenofovir and lamivudine (TLD) to virologically-suppressed patients on NNRTI-based first-line
Jin Li, MM, a, * Dabiao Chen, MD, b (D3 group) or tenofovir plus lamivudine and efavirenz (TDF + 3TC + EFV, TLE group) with subgroups of low viral load (LVL, ≤500,000 copies/mL) and high
This suggests recycling tenofovir and XTC with dolutegravir could provide an effective second-line opt
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
At week 24, 51/60 (85%, 95% CI 73-93%) were virologically suppressed, six had VL 50-100 copies/mL, one VL 100-1000 copies/mL, one
pinpoint red spots on the skin
In this real-life study, B/F/TAF led to a faster viral decline and fewer DRAEs compared to DTG+3TC
Background: Dual regimen dolutegravir (DTG) plus lamivudine (3TC) has demonstrated non-inferior e Li J, Chen D, Wen Z, Du Y, Huang Z, Zhong H, et al
Les effets secondaires sérieux ont été comparables entre les 2 groupes de même que les arrêts de traitement liés aux antirétroviraux (3%)
3nM and 6nM respectively)
Abbreviations: 3TC, lamivudine; DTG, dolutegravir; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TAF, tenofovir alafenamide
A week 48 viral load of less than 400 copies per milliliter was observed in 90
Take Triumeq or Triumeq PD according to your health care provider’s instructions
An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation Store dolutegravir 10-mg, 25-mg, and 50-mg tablets at room temperature, 68°F to 77°F (20°C to 25°C)
Dolutegravir / lamivudine (Dovato®) for treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection in adults and adolescents above 12 years of age weighing at least 40 kg, with no known or suspected resistance to the integrase inhibitor class, or lamivudine (September 2019) Recommended
dolutegravir, lamivudine and tenofovir alafenamide tablets is insufficient in these subpopulations
4) Dolutegravir and lamivudine combination contains a fixed amount of each medicine in the tablet